A
$ Value
$0
Shares
30,864
Price
$0
Filed
Mar 3
Insider
Name
Zielinski Anita A
Title
SVP, CAO and Controller
CIK
0001703384
Roles
Officer
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
48,214
Footnotes
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. | Total includes the automatic reinvestment of dividends.
Filing Info
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |